Patients Discontinuing Anti-Obesity Jabs Gain Back Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis suggests that individuals who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional lifestyle plans.

Research printed in a leading medical journal points out that while obese people can lose about a fifth of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"Users using such drugs need to be aware of the danger of quick weight regain when the therapy concludes," warns expert Dr. Susan Jebb.

Such speed of regain means a return to pre-treatment mass in about a year and a half.

Comparing Approaches

The study, which reviewed dozens of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.

The team point out that individuals who lose weight through dieting generally experience a less rapid weight regain—perhaps 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Doctors suggest the way of the injections accounts for the heightened weight return.

These medications imitate a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' results in appetite is uncontrolled, making excessive eating a significant risk."

A Lifelong Disease?

Health authorities advise the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals say that, considering the likelihood of relapse, the treatment is often ongoing.

This opinion is supported by pharmaceutical companies, who note that the results "underscore the persistent character of excess weight," comparing it to managing diseases like high blood pressure.

User Accounts

Individuals who have discontinued the jabs report a intense return of hunger.

"It felt as if something activating and I was suddenly starving," said a patient.

This difficulty is worsened if patients have not established sustainable lifestyle or habit modifications during therapy.

Growing Interest

Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Use is higher among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• Many access the medications through private healthcare rather than public health services.

Finally, researchers stress that while these medications are effective agents for shedding pounds, they are not a magic fix and maintained weight loss hinges on combined lifestyle management.